370 related articles for article (PubMed ID: 19214027)
1. Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients.
Hsu HJ; Wu MS
Am J Med Sci; 2009 Feb; 337(2):116-22. PubMed ID: 19214027
[TBL] [Abstract][Full Text] [Related]
2. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
[TBL] [Abstract][Full Text] [Related]
3. FGF23 in hemodialysis patients is associated with left ventricular hypertrophy and reduced ejection fraction.
Nielsen TL; Plesner LL; Warming PE; Mortensen OH; Iversen KK; Heaf JG
Nefrologia (Engl Ed); 2019; 39(3):258-268. PubMed ID: 30723045
[TBL] [Abstract][Full Text] [Related]
4. FGF23 and Left Ventricular Hypertrophy in Children with CKD.
Mitsnefes MM; Betoko A; Schneider MF; Salusky IB; Wolf MS; Jüppner H; Warady BA; Furth SL; Portale AA
Clin J Am Soc Nephrol; 2018 Jan; 13(1):45-52. PubMed ID: 29025789
[TBL] [Abstract][Full Text] [Related]
5. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.
Mirza MA; Larsson A; Melhus H; Lind L; Larsson TE
Atherosclerosis; 2009 Dec; 207(2):546-51. PubMed ID: 19524924
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor-23 and interleukin-6 are risk factors for left ventricular hypertrophy in peritoneal dialysis patients.
Liu WH; Zhou QL; Ao X; Yu HL; Peng WS; He N
J Cardiovasc Med (Hagerstown); 2012 Sep; 13(9):565-9. PubMed ID: 22728833
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients.
Sarmento-Dias M; Santos-Araújo C; Poínhos R; Oliveira B; Silva IS; Silva LS; Sousa MJ; Correia F; Pestana M
Clin Nephrol; 2016 Mar; 85(3):135-41. PubMed ID: 26833300
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 23 and left ventricular mass index in maintenance hemodialysis patients: standard versus long nocturnal hemodialysis.
Knap B; Večerić-Haler Ž; Benedik M; Buturović-Ponikvar J; Ponikvar R; Bren AF
Ther Apher Dial; 2013 Aug; 17(4):407-11. PubMed ID: 23931880
[TBL] [Abstract][Full Text] [Related]
9. Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease.
Sinha MD; Turner C; Booth CJ; Waller S; Rasmussen P; Goldsmith DJ; Simpson JM
Pediatr Nephrol; 2015 Oct; 30(10):1843-52. PubMed ID: 25975437
[TBL] [Abstract][Full Text] [Related]
10. Effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients: a randomized controlled trial (ETECAR-HD).
Dörr K; Kammer M; Reindl-Schwaighofer R; Lorenz M; Loewe C; Marculescu R; Erben R; Oberbauer R
Trials; 2019 Oct; 20(1):601. PubMed ID: 31651370
[TBL] [Abstract][Full Text] [Related]
11. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.
deFilippi C; Wasserman S; Rosanio S; Tiblier E; Sperger H; Tocchi M; Christenson R; Uretsky B; Smiley M; Gold J; Muniz H; Badalamenti J; Herzog C; Henrich W
JAMA; 2003 Jul; 290(3):353-9. PubMed ID: 12865376
[TBL] [Abstract][Full Text] [Related]
12. Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy.
Takashi Y; Kinoshita Y; Hori M; Ito N; Taguchi M; Fukumoto S
Endocr Res; 2017 May; 42(2):132-137. PubMed ID: 27754732
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 23 in chronic kidney disease: bridging the gap between bone mineral metabolism and left ventricular hypertrophy.
Canziani ME; Tomiyama C; Higa A; Draibe SA; Carvalho AB
Blood Purif; 2011; 31(1-3):26-32. PubMed ID: 21135546
[TBL] [Abstract][Full Text] [Related]
14. Hypoalbuminemia as a risk factor for progressive left-ventricular hypertrophy in hemodialysis patients.
Moon KH; Song IS; Yang WS; Shin YT; Kim SB; Song JK; Park JS
Am J Nephrol; 2000; 20(5):396-401. PubMed ID: 11092998
[TBL] [Abstract][Full Text] [Related]
15. [Left ventricular hypertrophy in patients with chronic renal failure treated by hemodialysis].
Wanic-Kossowska M; Lehmann P; Czekalski S
Pol Arch Med Wewn; 2002 Jun; 107(6):539-46. PubMed ID: 12375575
[TBL] [Abstract][Full Text] [Related]
16. Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients.
Kirkpantur A; Balci M; Gurbuz OA; Afsar B; Canbakan B; Akdemir R; Ayli MD
Nephrol Dial Transplant; 2011 Apr; 26(4):1346-54. PubMed ID: 20813767
[TBL] [Abstract][Full Text] [Related]
17. FGF23 induces left ventricular hypertrophy.
Faul C; Amaral AP; Oskouei B; Hu MC; Sloan A; Isakova T; Gutiérrez OM; Aguillon-Prada R; Lincoln J; Hare JM; Mundel P; Morales A; Scialla J; Fischer M; Soliman EZ; Chen J; Go AS; Rosas SE; Nessel L; Townsend RR; Feldman HI; St John Sutton M; Ojo A; Gadegbeku C; Di Marco GS; Reuter S; Kentrup D; Tiemann K; Brand M; Hill JA; Moe OW; Kuro-O M; Kusek JW; Keane MG; Wolf M
J Clin Invest; 2011 Nov; 121(11):4393-408. PubMed ID: 21985788
[TBL] [Abstract][Full Text] [Related]
18. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
Leifheit-Nestler M; Große Siemer R; Flasbart K; Richter B; Kirchhoff F; Ziegler WH; Klintschar M; Becker JU; Erbersdobler A; Aufricht C; Seeman T; Fischer DC; Faul C; Haffner D
Nephrol Dial Transplant; 2016 Jul; 31(7):1088-99. PubMed ID: 26681731
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor 23 (FGF23) level is associated with ultrafiltration rate in patients on hemodialysis.
Nishizawa Y; Hosoda Y; Horimoto A; Omae K; Ito K; Higuchi C; Sakura H; Nitta K; Ogawa T
Heart Vessels; 2021 Mar; 36(3):414-423. PubMed ID: 33000285
[TBL] [Abstract][Full Text] [Related]
20. QTc Interval Prolongation Is Independently Associated with FGF23 and Predicts Mortality in Predialysis Chronic Kidney Disease.
Sikaneta T; Ho N; Bellasi A; Mahdavi S; Taskapan H; Svendrovski A; Makanjee B; Roberts J; Wu G; Nathoo B; Tam P
Cardiorenal Med; 2024; 14(1):45-57. PubMed ID: 37963445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]